Steve Olsen

Suggest Changes
Learn More
BACKGROUND AND OBJECTIVE Trastuzumab emtansine (T-DM1) is an antibody-drug conjugate recently approved by the US Food and Drug Administration for the treatment of human epidermal growth factor(More)
  • 1